1036 studies found for:    IL13
Show Display Options
Rank Status Study
21 Completed The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: PF-03654764;   Drug: Allegra;   Drug: Allegra-D;   Drug: Placebo
22 Completed Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms
Condition: Seasonal Allergic Rhinitis
Interventions: Dietary Supplement: Lectranal;   Dietary Supplement: placebo
23 Recruiting Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean
Conditions: Allergic Rhinitis;   Perennial Allergic Rhinitis;   Non-seasonal Allergic Rhinitis
Interventions: Drug: AGR tablet;   Drug: Placebo (for AGR tablet and/or Active Comparator);   Drug: Active Comparator
24 Completed
Has Results
Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)
Condition: Perennial Allergic Rhinitis
Interventions: Drug: montelukast sodium;   Drug: Comparator: cetirizine;   Drug: Comparator: placebo
25 Completed
Has Results
Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Comparator: montelukast/loratadine;   Drug: Comparator: montelukast;   Drug: Comparator: loratadine;   Drug: Comparator: placebo
26 Completed A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults
Condition: Allergic Rhinitis
Interventions: Drug: JNJ-17166864;   Drug: Placebo
27 Completed
Has Results
Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: montelukast sodium;   Drug: Comparator: loratadine;   Drug: Comparator: Placebo
28 Completed
Has Results
Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: montelukast sodium;   Drug: Comparator: loratadine;   Drug: Comparator: placebo
29 Completed
Has Results
Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Comparator: montelukast;   Drug: Comparator: loratadine;   Drug: Comparator: placebo;   Drug: Comparator: montelukast/loratadine
30 Completed
Has Results
A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: montelukast sodium;   Drug: Comparator: loratadine;   Drug: Comparator: placebo
31 Recruiting NoAL (HPMC) in Combination With Oxymetazoline in Patients With Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: Oxymetazoline;   Other: Hydroxyl-propyl-methyl cellulose powder;   Other: Placebo (lactose powder)
32 Not yet recruiting Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Ependymoblastoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Adult Pineal Gland Astrocytoma;   Recurrent Adult Brain Tumor
Interventions: Biological: IL13Rα2-specific, hinge-optimized, 41BB-costimulatory CAR/truncated CD19-expressing T lymphocytes;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
33 Not yet recruiting Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Other: Grass pollen sublingual immunotherapy tablet;   Drug: Control
34 Completed A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis
Conditions: Allergic Rhinitis;   Rhinitis, Allergic, Seasonal
Interventions: Drug: GSK256066;   Drug: azelastine hydrochloride
35 Recruiting the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis
Conditions: Perennial Allergic Rhinitis;   Probiotics;   Lactobacillus Paracasei GMNL-32 (eN-Lac®)
Interventions: Biological: eN-Lac®;   Other: Placebo
36 Completed A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)
Conditions: Allergic Rhinitis;   Rhinitis, Allergic, Seasonal
Interventions: Drug: GSK256066;   Drug: fluticasone propionate
37 Completed Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: ACT-129968;   Drug: Placebo;   Drug: Cetirizine
38 Completed Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)
Conditions: Perennial Allergic Rhinitis;   Allergic Rhinitis;   Hay Fever
Intervention: Drug: Ciclesonide
39 Completed Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)
Conditions: Perennial Allergic Rhinitis;   Allergic Rhinitis;   Hay Fever
Intervention: Drug: Ciclesonide
40 Terminated Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting
Conditions: Rhinitis, Allergic, Seasonal;   Seasonal Allergic Rhinitis
Intervention: Drug: Fluticasone furoate nasal spray

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years